Researchers share first human data on new interventional shunt procedure for HFpEF

A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial - The Lancet

No-implant Interatrial Shunt Device to Treat Heart Failure Patients Reveals Promising Multi-center Clinical Data

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial - The Lancet

Interatrial Shunts to Treat Heart Failure - Cardiac Interventions Today

Update on Atrial Shunt Therapy for Treatment of Heart Failure - Structural Heart

Researchers share first human data on new interventional shunt procedure for HFpEF

One‐year results of the first‐in‐man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study - Paitazoglou - 2021 - European Journal of Heart

New Heart Failure Devices and Drugs to Treat Heart Failure

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction - ScienceDirect

Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience

Interatrial Shunting for Treating Acute and Chronic Left Heart Failure